Abbott Laboratories ABT
NYSE ABT
$109.95 -3.63 (-3.20%)
At close: Nov 6, 2026 · 4:00 PM EST

Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026)

Updated

Abbott Laboratories' Income from Continuing Operations was $928 million in Q2 2026, down 47.8% from $1.78 billion a year earlier and down 13.8% from the prior quarter.

Analysis

Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Abbott Laboratories' Income from Continuing Operations was $5.43 billion through Jun 30, 2026, down 61.2% year-over-year; for FY2025, it was $6.52 billion, down 51.3% from FY2024.

  • Income from Continuing Operations shows a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
  • In earlier years, Income from Continuing Operations was $13.4 billion in FY2024 (+134.2%), $5.72 billion in FY2023 (-17.5%), $6.93 billion in FY2022 (-2.0%) and $7.07 billion in FY2021 (+58.2%).
  • The Q2 2026 figure marks the lowest quarterly Income from Continuing Operations since Q2 2020.
  • Compared with a year earlier, Income from Continuing Operations has declined for four straight quarters, with growth averaging 48.9% over the last eight quarters.
  • The best year-over-year quarter for Income from Continuing Operations over five years was Q4 2024 (growth of 479.0%); the worst was Q4 2025 (a decline of 80.8%).
  • Per Business Quant data, ABT's Income from Continuing Operations in the three quarters before Q2 2026 was $1.08 billion (Q1 2026), $1.78 billion (Q4 2025) and $1.64 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn 1.74 Bn
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn 920.00 Mn
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn 1.21 Bn
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn 524.40 Mn
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn 1.48 Bn
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn -237.00 Mn
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn 580.00 Mn
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn 301.40 Mn
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn 451.00 Mn
10 Agilent Technologies 49.29 Bn 42.18 Bn 1.04 Bn 362.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 920.00 Mn
Jun 30, 2026 928.00 Mn
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.78 Bn
Sep 30, 2025 1.64 Bn
Jun 30, 2025 1.78 Bn
Mar 31, 2025 1.33 Bn
Dec 31, 2024 9.23 Bn
Sep 30, 2024 1.65 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 1.59 Bn
Sep 30, 2023 1.44 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.03 Bn
Sep 30, 2022 1.44 Bn
Jun 30, 2022 2.02 Bn
Mar 31, 2022 2.45 Bn
Dec 31, 2021 1.99 Bn
API Access

Abbott Laboratories Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ABT&period=max&api_key=YOUR_API_KEY